{"public_id":"co_3b1a781d519592011745023e9646e499","status":"active","merged_into_public_id":null,"resolved_public_id":"co_3b1a781d519592011745023e9646e499","name":"mildly antagonistic","description":"A weak interaction in which the combined effect is less favorable than expected.","aliases":[],"types":["interaction property"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":27608012,"title":"In Vitro Interactions between Piperaquine, Dihydroartemisinin, and Other Conventional and Novel Antimalarial Drugs","citation_count":28,"url":"https://sah.borca.ai/papers/27608012"}],"claims":[{"public_id":"cl_a1bdc319081d680de44b0b3ae160e9c1","text":"The clinical significance of mildly antagonistic dihydroartemisinin combinations is uncertain and may become important if parasite drug sensitivity declines.","corpus_id":27608012,"url":"https://sah.borca.ai/claims/cl_a1bdc319081d680de44b0b3ae160e9c1"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_3b1a781d519592011745023e9646e499","url":"https://sah.borca.ai/concepts/co_3b1a781d519592011745023e9646e499"}